LONG-TERM THERAPY WITH BENDAVIA (MTP-131), A NOVEL MITOCHONDRIA-TARGETING PEPTIDE, REDUCES TOTAL BURDEN OF REACTIVE OXYGEN SPECIES IN LV MYOCARDIUM AND PLASMA OF DOGS WITH ADVANCED HEART FAILURE